Controlled Pharmacodynamics with Melanin Targeted Drug Delivery to the Eye
Description of the granted funding
Ocular diseases are common and growing problem that endangers the vision of millions of patients. Drug treatment of glaucoma is accomplished with frequently applied eye drops that are difficult to use, leading to poor patient compliance. In age-related macular degeneration the medications are given as direct injections to the eye, but this is burdensome to patients and healthcare. This project aims to develop long acting therapeutics that are based on drug binding to melanin pigment in the eye. New compounds will be designed, synthesized and tested. Furthermore, computational models are developed to facilitate the development of long-acting ocular injections and eye drops for the treatment of glaucoma and age-related macular degeneration.
Show moreStarting year
2021
End year
2023
Granted funding
Other information
Funding decision number
343138
Fields of science
Pharmacy
Research fields
Farmasia
Identified topics
eyes, eye diseases